Cerevel Therapeutics Holdings, Inc.
Cerevel Therapeutics Holdings, Inc. (CERE) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001805387 · CERE · NASDAQ · as of Jun 9, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001805387 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) has submitted 448 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2020. As a Healthcare sector company with CIK 0001805387, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is Cerevel Therapeutics Holdings, Inc.'s most comprehensive regulatory disclosure. The most recent Cerevel Therapeutics Holdings, Inc. 10-K was filed on 2024-04-26 for fiscal year ending 2024. Historical CERE 10-K annual reports are available from 2020 through 2024.
Investors researching Cerevel Therapeutics Holdings, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
CERE SEC Filings · 8 questionsCerevel Therapeutics Holdings, Inc. (CERE) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 448 filings and access original documents at no cost. Cerevel Therapeutics Holdings, Inc.'s CIK is 0001805387.